Engineering the Future: The Evolution of Multi-specific and Context-Aware Antibodies
In the rapidly shifting landscape of biotherapeutics, the traditional monoclonal antibody (mAb) is no longer the only protagonist. While mAbs have revolutionized the treatment of cancer and autoimmune diseases over the past few decades, the frontier of antibody engineering has moved toward multi-specificity and environmental responsiveness.
The Power of Dual Targeting: Bispecific and...
0 Comments
0 Shares
67 Views
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt